Company Filing History:
Years Active: 2014
Title: Maria Luisa Sanz Larruga: Innovator in Immune Response Technologies
Introduction
Maria Luisa Sanz Larruga is a prominent inventor based in Pamplona, Spain. She has made significant contributions to the field of immunotherapy through her innovative research and development of immune response stimulating compositions. Her work focuses on utilizing nanoparticles to enhance immune responses, which has important implications for vaccines and immunotherapy.
Latest Patents
Maria Luisa Sanz Larruga holds a patent for an "Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer." This composition is designed to stimulate an immune response in subjects by utilizing nanoparticles made from a copolymer of methyl vinyl ether and maleic anhydride. The nanoparticles can also incorporate allergens, antigens, or immunostimulating agents, making them versatile tools in the field of immunotherapy.
Career Highlights
Throughout her career, Maria Luisa has worked with esteemed institutions such as the University of Navarra and the Scientific and Technological Institute of Navarra, S.A. Her research has been pivotal in advancing the understanding of how nanoparticles can be used to improve immune responses, thereby contributing to the development of more effective vaccines and therapies.
Collaborations
Maria Luisa has collaborated with notable colleagues, including Juan Manuel Irache Garreta and Carlos Gamazo De La Rasilla. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the field of immunology.
Conclusion
Maria Luisa Sanz Larruga is a trailblazer in the realm of immune response technologies, with her innovative patent and collaborative efforts paving the way for advancements in immunotherapy. Her work exemplifies the impact of scientific research on public health and the potential for future innovations in this critical area.